[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
3,493 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-07-15 | Class I | Adams Extract & Spice LLCH-1139-2026 | Undeclared Sesame allergen | Documentation & Change Control |
| 2026-07-15 | Class I | Fresh & Ready Foods LLCH-1149-2026 | Raw breaded chicken patties were inadvertently used in the ready to eat Burger Chicken Fillet sandwich. Raw breaded chicken patties pose a risk of foodborne illness due to the potential presence of Salmonella. | Environmental Monitoring |
| 2026-07-15 | Class I | Adams Extract & Spice LLCH-1141-2026 | Undeclared Sesame allergen | Documentation & Change Control |
| 2026-07-15 | Class II | Specialty Bakers, LLCH-1145-2026 | Undeclared Allergen (Soy) | Documentation & Change Control |
| 2026-07-15 | Class II | Wise Foods IncH-1146-2026 | The product contains undeclared Yellow 5 and 6, Blue 1, and unapproved Red 3. | Documentation & Change Control |
| 2026-07-15 | Class I | Adams Extract & Spice LLCH-1140-2026 | Undeclared Sesame allergen | Documentation & Change Control |
| 2026-07-15 | Class II | Bear Stewart CoH-1143-2026 | undeclared soy | Documentation & Change Control |
| 2026-07-15 | Class I | Adams Extract & Spice LLCH-1138-2026 | Undeclared Sesame allergen | Documentation & Change Control |
| 2026-07-15 | Class II | QuVa Pharma, Inc.D-0664-2026 | Failed Impurities/Degradation Specifications | Validation & Qualification |
| 2026-07-15 | Class II | Wondermade LLCH-1147-2026 | Foreign material: small metal pieces | Environmental Monitoring |
| 2026-07-15 | Class II | Gasco Industrial Corp.D-0669-2026 | Subpotent drug | Validation & Qualification |
| 2026-07-15 | Class II | Reliance Life Sciences Private LimitedD-0674-2026 | Lack of Sterility Assurance | Environmental Monitoring |
| 2026-07-15 | Class II | Reliance Life Sciences Private LimitedD-0671-2026 | Lack of Sterility Assurance | Environmental Monitoring |
| 2026-07-15 | Class II | Reliance Life Sciences Private LimitedD-0673-2026 | Lack of Sterility Assurance | Environmental Monitoring |
| 2026-07-15 | Class II | Gasco Industrial Corp.D-0668-2026 | Subpotent drug | Validation & Qualification |
| 2026-07-15 | Class II | Reliance Life Sciences Private LimitedD-0672-2026 | Lack of Sterility Assurance | Environmental Monitoring |
| 2026-07-15 | Class II | Shimoga ChemicalsD-0691-2026 | cGMP deviations | Risk Management & CAPA |
| 2026-07-15 | Class II | Medline Industries, LPZ-2695-2026 | Convenience Kits contain Covidien Mon-a-Therm General Purpose Temperature Probes Size 9 Fr. Medtronic has issued a recall of specific production lots of the Covidien Mon-a-Therm general purpose temperature probe-size 9 due to an error in its distribution control process. | Risk Management & CAPA |
| 2026-07-15 | Class II | Gasco Industrial Corp.D-0670-2026 | Subpotent drug | Validation & Qualification |
| 2026-07-15 | Class II | Gasco Industrial Corp.D-0667-2026 | Subpotent drug | Validation & Qualification |
| 2026-07-15 | Class II | Gasco Industrial Corp.D-0666-2026 | Subpotent drug | Validation & Qualification |
| 2026-07-15 | Class II | Elekta, Inc.Z-2711-2026 | Due to safety concerns regarding the detachment of the tip of the intrauterine tube (IU tube) that may remain within a patient. | — |
| 2026-07-15 | Class II | BioMed Laboratories, LLC.D-0663-2026 | Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification. | Validation & Qualification |
| 2026-07-15 | Class II | Gasco Industrial Corp.D-0665-2026 | Subpotent drug | Validation & Qualification |
| 2026-07-15 | Class II | ONESOURCE SPECIALTY PHARMA LIMITEDD-0662-2026 | Failed Impurities/Degradation Specifications | Validation & Qualification |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.